Sexually mature gilts (n = 20) were actively immunized against GnRH. Primary and booster immunizations of GnRH conjugated to bovine serum albumin induced production of antibodies in all gilts. Nineteen of the gilts became acyclie with suppressed concentrations of gonadotropins and estradiol. Intravenous challenges with 100/~g GnRH and 5 btg D-(Ala 6 , des-Gly-NH210) ethylamide GnRH (a GnRH agonist that did not cross-react with antibodies produced by the gilts) caused release of LH and FSH, indicating maintenance of secretory capacity of pituitary gonadotropes in the immunized animals. Gilts were given 100 ng GnRH agonist at 2-h intervals for 72 h (n = 4) or 144 h (n = 10) or did not receive agonist (n = 5). Blood samples were taken every 6 h, and detectable concentrations of LH were observed in 42% and 52% of samples taken from gilts treated with or without agonist. In contrast, serum concentrations of FSH and estradiol were undetectable. Reproductive tracts and anterior pituitaries were taken from gilts at the conclusion of pulsatile administration of GnRH agonist or at 144 h for controls. Pituitary concentration of LH and FSH, uterine wet and dry weight, and size of the uterus were similar among groups. Paired ovarian weights for treated gilts pulsed with GnRH agonist for 72 h were heavier (P < .05); however, ovaries from all immunized gilts were atrophied without follicular structures. These results indicate that the regimen of GnRH agonist used did not overcome the effects of active immunization of the gilt against GnRH.
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3Dept. of Anita. Sci. Received October 13, 1987 . Accepted March 12, 1988 of GnRH. Carpenter and Anderson (1985) and Lutz et al. (1985) have shown that pulsatile administration of GnRH induces follicular growth in prepubertal gilts, resulting in estrus and ovulation. Pulses of GnRH also have been used to induce follicular growth, estrus and ovulation in lactating (Cox and Britt, 1982) and anestrous sows (Armstrong and Britt, 1985) . Active immunization of the gilt against GnRH results in cessation of estrous cycles and inhibition in secretion of LH, FSH and gonadal steroids (Esbenshade and Britt, 1985) . Attempts to induce follicular development with pregnant mare's serum gonadotropin (PMSG) and an extract from porcine pituitary glands in gilts actively immunized against GnRH were not successful (Esbenshade, 1987) . Because the treatments used in that study may not have been of sufficient intensity or duration to overcome the complete loss of 2209 J. Anim. Sci. 66:2209-2215 gonadotropin support by immunoneutralization of GnRH, the objective of this study was to induce follicular development in gilts actively immunized against GnRH by simulating the natural release of GnRH more closely with pulses of GnRH agonist.
Materials and Methods
Animals and Experimental Protocol. Twenty crossbred gilts averaging 238 d of age were maintained in 1.5 x 5-m pens containing two to five animals each. The study was initiated in June, after all gilts had exhibited at least one estrous cycle. Gilts were observed once daily for estrus in the presence of a boar beginning on wk -4 (Wk 0 = week of primary immunization). Animals were transferred to individual stalls and assigned to one of four treatment groups during wk 11.
Nineteen gilts were nonsurgically fitted with indwelling anterior vena cava cannulas (Ford and Maurer, 1978) during wk 11. On the day after cannulation, gilts were given 100 ~g GnRH 4 at 1000 and 5 /ag D-(Ala 6, des-Gly-NH210) ethylamide GnRH 4 (GnRH agonist) at 1300. Gilts then were randomly assigned to receive pulses of 100 ng GnRH agonist at 2-h intervals for 72 h (Group 1; n = 5), for 144 h (Group 2; n = 4 and Group 3; n = 5) or not treated (Group 4; n = 5). Treatments were begun at 1200 on the 2nd d after cannulation. Gilts in Groups 1 and 2 were anesthetized with xylazine and ketamin hydrochloride and euthanized 72 and 144 h after initiation of pulses of GnRH agonist; gilts in Group 4 were euthanized at 144 h. Gilts in Group 3 were given pulses of GnRH agonist at 2-h intervals for 144 h, but were not killed at the end of the treatment period.
GnRH Immunization Procedures.
GnRH was conjugated to bovine serum albumin by the carbodiimide reaction (Fraser et al., 1974) , and 5 mg of conjugate was given in Freund's complete adjuvant as the primary immunization, followed by 1-mg boosters in incomplete adjuvant as previously described by Esbenshade and Britt (1985) . The primary immunization (wk 0) was followed by booster injections on wk 4, 7 and 10.
Blood Sampling. Blood samples were col-4 Sigma Chemical Co., St. Louis, MO. lected via puncture of the vena cava every 2 wk beginning at wk -2 and continuing through wk 10. On the day after cannulation, blood samples were obtained from all gilts every 30 min from 0600 to 1000 for estimation of pretreatment gonadotropin baseline concentrations and at O, 15, 30, 45, 60, 90, 120, 150 and 180 min after administering GnRH and GnRH agonist.
Blood samples also were collected every 6 h beginning 12 h before pulsatile hormone treatment and continuing until the animals were euthanized. In addition, blood samples were obtained at 15-rain intervals between 1200 and 1800 on d 0 and d 2 for Group 1 and on d 0, 2 and 4 for Group 2 (d 0 = 1st d of pulsatile treatment).
Blood samples were allowed to clot at 4~ and serum was collected by decanting the supernatant following centrifugation at 1,700 x g for 30 min. Serum was stored at -20~ until assayed. Progesterone was measured in samples collected during immunization; estradiol, LH and FSH were measured in samples collected every 6 h; and LH and FSH were measured in samples collected at 15-rain intervals on d 0, 2 and 4.
Tissue Recovery and Processing. Following exsanguination, pituitary glands were removed and stored in liquid N until prepared for hormone analysis. Reproductive tracts were excised, placed on ice and transported to the laboratory. Ovaries were trimmed of excess tissue and weighed. One ovary from each gilt was minced with a single-edged razor blade, blotted dry and reweighed to determine follicular fluid weight. The contralateral ovary was fixed in Bouin's fluid for 12 h, thoroughly rinsed in 50% ethanol and stored in 70% ethanol until processed. Ovaries were sectioned serially at 10/zm; every 10th section was mounted and stained with hematoxylin for histological examination. All follicles with more than four layers of granulosa cells were counted, grouped as antral, beginning antral or nonantral follicles and classified as either atretic or nonatretic. A follicle was classified atretic when more than four pyknotic bodies were observed in the section that contained the oocyte.
Uteri were carefully trimmed of excess tissue and weighed and uterine horn lengths were measured. A 10-cm section was excised from the uterine horn, weighed and dried in a mechanical convection oven until a constant weight was attained.
Each pituitary gland was removed from liquid N and allowed to thaw to 0~ After weighing the pituitary gland, ice-cold .01 M phosphate-buffered saline containing .1% gelatin (pH 7.4) was added at a rate of 1 ml per 200 mg tissue. Pituitary glands were homogenized in an ice bath and centrifuged for 25 rain at 1,700 x g and 4~ the supernatant fluid was decanted and stored at -20~ until assayed for LH and FSH.
Antibody Titer, Cross-reactivity and Hormone Analyses. Antibody titers to GnRH were measured in serial dilutions of sera by the procedure of Esbenshade and Britt (1985) . The titer was expressed as the dilution that bound 50% of the [12sI]-GnRH added to the sera.
Cross-reactivity of GnRH agonist with GnRH antibodies was examined in a competitive binding RIA of serum harvested from individual gilts at the end of their respective treatment periods. Diluted serum, previously determined to bind 50% of radioiodinated GnRH, was incubated overnight with [12sI]-GnRH (approximately 26,000 counts/min) and serial dilutions of GnRH or GnRH agonist from 0 to 1,000 ng in a final volume of 300 /A. Free labeled GnRH was separated from bound by adding five volumes of ice-cold ethanol, centrifuging, and decanting the supernatant fluid. Bound [12sI]-GnRH was estimated by counting the pellet. Bound [12s I]-GnRH (0 ng GnRH or GnRH agonist) was expressed as 100% binding for each gilt. Displacement of [12sI]-GnRH by GnRH or GnRH ,agonist was expressed as percentage of total binding (bound over total) and was determined at each concentration.
Previously reported and validated RIA were used to quantify serum concentrations of progesterone (Stevenson et al., 1981) and estradiol-17/3 (Cox and Britt, 1982) . Plasma LH was quantified by RIA (Niswender et al., 1970; Stevenson et al., 1981) with porcine LH (LER-786-3) used as the radioiodinated antigen and standard. Average sensitivity of the LH assays, determined at 90% of total binding, was .3 ng/ ml. Intraassay and interassay coefficients of variation for the LH assays were 17 and 26%, respectively.
Serum FSH was quantified by RIA procedures using anti-pFSH (USDA-IO-IO10) and pFSH as radioiodinated antigen (USDA-FSH-PP1) and standard (USDA-pFSH-B-1; Guthrie and Bolt, 1983 , as modified by Esbenshade and Britt, 1985) . Average sensitivity of the assay was 20 ng/ml. Intraassay and interassay coefficients of variation were 14 and 15%, respectively.
Statistical Analysis. Gilts immunized against
GnRH responded to GnRH or GnRH agonist if the following criteria were met: 1) concentrations of LH or FSH had to reach a peak within 30 min of injection, 2) amplitude of the LH or FSH peak had to be greater than the sensitivities of the respective assays and 3) concentration of LH at its peak had to be greater than two standard deviations above pretreatment LH concentrations. Because serum FSH was not detectable in preinjection samples, the last criterion was not used to identify FSH release. Segmented areas under response curves were used to quantitate LH and FSH release.
Ovarian and pituitary parameters were analyzed by least squares analysis of variance (Barr et al., 1976) . Orthogonal contrasts were made between Group 1 and Groups 2 and 4 and between Group 2 and Group 4.
R esu Its
Nineteen gilts became acyclic during the immunization period, with last estrus exhibited at wk 3 (n--2), 4 (n = 5), 6 (n = 5), 7 (n = 6) or 10 (n = 1). Antibody titer in these gilts averaged 1:14,000 and ranged from 1:100 to 1:70,000. Data were deleted from one gilt that did not respond to the immunization procedure. Acyclic gilts had undetectable concentrations of gonadotropins and estradiol at the beginning of the experiment.
Mean displacement of [12sI]-GnRH from antibodies in sera of individual animals by increasing concentrations of GnRH and GnRH agonist is illustrated in Figure  1 . Cross-reactivity of antisera and GnRH agonist averaged less than .1%.
Mean concentrations of LH and FSH in samples taken the day after cannulation and following treatment with GnRH and GnRH agonist are illustrated in Figure 2 . Administration of 100 gtg GnRIT failed to induce release of LH or FSH in 15 of the gilts, but induced surges of LH in one gilt and of both LH and FSH in three gilts. When the GnRH agonist was given, 11 gilts responded with surges of both gonadotropins, six gilts released only LH and two gilts failed to respond. There were no significant correlations between an individual's LH and FSH response to exogen- Sample Number Figure 2 . Mean serum concentration of luteinizing hormone (LH; o) and follicle-stimulating hormone (FSH; 9 ) in gilts actively immunized against gonadotropin-releasing hormone and given 100 /~g GnRH and 5 #g D-(Ala s , des.NH 2 l0 ) ethylamide (GnRH-A). Sample number refers to blood samples taken every 30 rain. Standard errors were proportional to the mean and ranged from .1 to .5 and 0 to 5 for LH and FSH, respectively. bTreatments were: Group 1, pulses of 100 ng D-(AIa 6 , des-Gly-NH z 10 ) ethylamide GnRH (GnRH agonist) at 2-h intervals for 72 h; Group 2, pulses of 100 ng GnRH agonist for 144 h; and Group 4 not treated. P < .05.
of samples from gilts pulsed with GnRH agonist or control gilts, respectively. Least squares mean LH concentrations for Groups 1, 2 and 4 were, respectively, .38, .35 and .32 ng/ml (SE = .02; P > .05).
Identifiable LH surges were temporally related to 41% of pulses of GnRH agonist administered on d 0, whereas only 14% and 18% of the GnRH agonist pulses resulted in LH secretory episodes when given on d 2 and 4, respectively. Amplitudes of LH pulses were .56 + .17, .50 -+ .27 and .66 + .15 ng/ml (X + SE) when measured on d 0, 2 and 4, respectively.
Least squares analysis of variance of data from measurements of reproductive tracts and pituitary glands are presented in Table 1 . There were no differences among groups in uterine wet weights~ dry weights or length of the horns. Anterior pituitary weights and concentration of LH and FSH were similar among treatments.
Ovaries from all gilts were devoid of morphologically distinct surface structures. Although paired ovarian weights were heavier (P < .05) for gilts in Group 1 compared with gilts in Groups 2 and 4, follicular fluid weights did not differ among treatments. Histological observations indicated no differences among groups in numbers of antra1, beginning antral or nonantral follicles or in the incidence of atresia (Table 2) . Initial growth of primary follicles occurs independent of pituitary gonadotropins and provides a population of follicles from which certain ones can be recruited and developed to ovulatory size given appropriate gonadotropin stimuli (Peters et al., 1975; Foxcroft and Hunter, 1985) . In the present study, follicular development proceeded from one layer of granulosa cells to the beginning of antral formation in the absence of hypothalamic GnRH and gonadotropins, and this was not influenced by treatment with pulses of GnRH agonist. Although atresia can occur at every stage of development, the incidence of atresia has generally been in the range of 30 to 60% (Ryan, 1981) . In contrast, almost all follicles recorded in our study with four layers of granulosa cells or more were atretic, based on the presence of pyknotic bodies. Incidence of atresia did not change after treatment with pulses of GnRH agonist in this study or after PMSG or pituitary extract, as reported previously by Esbenshade (1987) . Collectively, these results provide further evidence that hypothalamic GnRH and gonadotropins are not involved in recruitment of primary follicles.
Because not all pulses of GnRH agonist resulted in discernible LH release, it is possible that the pituitary glands of gilts deprived of GnRH stimulation for long periods of time may have lost GnRH receptors. Endogenous GnRH is essential for maintenance of pituitary GnRH receptors and can promote increases in amplitude of LH release by re-sensitization of GnRH receptors in the pituitary gland (Frager et al., 1981; Clayton et al, 1982) . The magnitude of gonadotropin release in this study decreased over time and may have contributed to the lack of follicular growth and estradiol production.
